Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000902664-25-005039·SAB Biotherapeutics, Inc.
Schedule 13G ownership disclosure
SAB Biotherapeutics, Inc.
Common Stock, par value $0.0001 per share · CUSIP: 78397T202
Event date: 2025-09-30
- Filing-level shares
- 7,125,881.00
- Percent of class
- 9.9%
- Woodline Partners LP
Shares: 7,125,881.00 · Class: 9.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-25-005039
- Form type
- SCHEDULE 13G
- Filer
- SAB Biotherapeutics, Inc.
- CIK
- CIK 1833214
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership